All research papers

Detection of calcium-associated nociceptive activity in neuropathic pain models using [51Mn]MnCl2 PET/MR

Biological and Health Effects of High-Dose and Repeated X-Ray Exposure: A Systematic Review

Recent advances in PSMA therapy - from beta to alpha

Progress in the application of ¹⁷⁷Lu- and ²²⁵Ac-targeted radionuclide therapy in pancreatic ductal adenocarcinoma.

Memory circuit dosimetry in patients with brain metastases treated with Sparing Memory with Advanced Radiosurgery Targeting (SMART) technique.

Occupational exposure assessment in ROLL procedures with Tc-99m: A Monte Carlo simulation approach.

68 Ga-FAPI-04 PET/CT Findings in Primary Hyperoxaluria Type 1.

Transformation of vestibular schwannomas into malignant peripheral sheath tumors: a systematic review and pooled analysis of patient characteristics and survival outcomes.

Radiosynthesis and preclinical evaluation of [¹¹C]Methyl-V-0219, a small molecule glucagon-like peptide-1 allosteric modulator for PET brain imaging.

Uncommon Concurrent Retinal and Cerebral Metastasis in High-risk Neuroblastoma: Diagnostic Utility of 68Ga-DOTATATE PET/CT Despite Negative 18F-FDG PET/CT.

Vertical miscentering increases eye lens radiation dose and degrades image quality in pediatric head CT: insights from an in-house heterogeneous phantom.

Clinical indications and implications of metastasis-directed therapy and primary-site treatment in metastatic urothelial carcinoma.

The use of Perspex-based devices in patient specific quality assurance of Acuros XB plans.

Perspective on production of radioisotopes via nuclear fusion reactors.

Determination of institute specific CTV to PTV prostate margins using the 2020 BIR IGRT geometric uncertainty guidelines for a conventional linear accelerator.

Clinical evaluation of Chang attenuation-correction parameterization for CT-free 177Lu SPECT organ quantification: implications for safety dosimetry.

Targeting the TRA-1-60 Glycoepitope Enables Selective ImmunoPET Imaging of Ovarian Cancer

Explainable dual-task deep learning model for recurrence prediction and dose-sensitive region identification in HNC radiotherapy.

Stereotactic radiotherapy in brain metastases: SRS/FSRT paradox and preferences of radiation oncologists in Türkiye (TROD 10-010 study).

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: Research Summary.

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

Tolerability of [¹⁶¹Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

Prognostic Value of [¹⁸F]FDG PET Combined with [⁶⁸Ga]Ga-PSMA PET as Pretreatment Imaging in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with [¹⁷⁷Lu]Lu-PSMA-617.

Clinical Trial Protocol for LPS-Boost: Intensified [¹⁷⁷Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.

Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [¹⁷⁷Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.

Using 18F-FDG and 68Ga-PSMA-11 PET/CT to evaluate salivary glands in Sjögren's Disease: Implications for Treatment Stratification

Thyroxine withdrawal prior to radioiodine therapy in papillary thyroid carcinoma - current scenarios.

Multiple Radioiodine-avid Skin Metastases From Thyroid Carcinoma Detected on Posttherapy 131I SPECT/CT.

SSTR Antagonist PET/CT Unveils Occult Hepatic Metastases in Rectal Neuroendocrine Tumor: Superiority Over 68Ga-DOTANOC and Clinical Upstaging.

Normal tissue complication probability models of late cardiopulmonary toxicity following deep inspiration breath hold for breast cancer adjuvant radiotherapy.

Conditional diffusion models for high-fidelity synthetic CT generation from CBCT in nasopharyngeal carcinoma adaptive radiotherapy: a multi-center study.

LINAC-based single-isocenter stereotactic radiotherapy for multiple brain metastases.

Intervention or Conservative Management for Symptomatic Cerebral Cavernous Malformations: A Prospective, Population-Based Cohort Study.

Long-term control after stereotactic body radiotherapy for perineal recurrence of prostate cancer after radical prostatectomy and radiotherapy: A case report and review of the literature.

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Impact of Volume and Image Strategy on Dose Prescription Accuracy in Lung Stereotactic Body Radiation Therapy.

Comparative Radiolabelling of PSMA I&T and Somatostatin Analogues with ¹⁷⁷Lu and ⁹⁰Y: The Impact of SPE Purification

Radiation dose of photon-counting CT in pediatric head examinations: an anthropomorphic phantom study

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.

[Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes.

EXPRESS: Positional Impact on Ocular Lens and Thyroid Radiation Doses During Feline Cranial CT: A TLD Study of 70 Cases.

Deep learning for CT-less attenuation correction synthesis in non-small cell lung cancer: A proof-of-concept evaluated for quantitative and physical characteristics.

Fluorodeoxyglucose PET in Radiation Oncology Planning.

Planning CT-Guided Dual-Branch Attention GAN for Longitudinal CBCT Outpainting in Adaptive Radiotherapy.

A Predictive Framework for Detecting Non-Independent Tumor Dynamics in Longitudinal MR-Guided Radiotherapy

Biologically adaptive radiation oncology in oligometastatic and oligoprogressive disease: MR- and CBCT-guided adaptation, molecular imaging, dose painting, biomarkers, and AI.

Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline.

PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) AND THE PITUITARY: SAFETY AND EFFICACY.

Advances in Somatostatin-Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives

A Case of FDG-Avid but FAPI-Negative Peritoneal Metastatic Gastrointestinal Stromal Tumor.

Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.

Construction of a survival prediction model and analysis of influencing factors for brain metastasis in non-small cell lung cancer based on multi‑parameter clinical data.

KA-TMoE: A Deep Learning Method Using Time-Series CT Radiomics to Predict Post-Radiotherapy Rib Fractures in NSCLC Patients.

Dual‑targeted radioligand therapy with [¹⁷⁷Lu]Lu‑DOTATATE plus [¹⁷⁷Lu]Lu‑DOTA‑IBA for bone metastases from neuroendocrine neoplasms: a prospective pilot study.

Beyond geometric accuracy: Evaluation of an MRI-based autocontouring prototype for brain and prostate radiotherapy

Determinants of physicians' risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer.

Optimal timing of post-therapeutic [¹³¹I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review.

Efficacy, safety, and quality of life outcomes of [¹⁷⁷Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.

Safety and efficacy of delivering systemic treatments concomitantly with whole-brain radiotherapy: a prospective, observational, single-institution study.

Pain response after palliative-intent radiotherapy for pancreatic cancer: a systematic review.